S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NVS

Novartis (NVS)

Novartis AG

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
23/04/2024	21:25	IH Market News	Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News	NYSE:NVS	Novartis AG
16/04/2024	04:00	PR Newswire (US)	New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)	NYSE:NVS	Novartis AG
11/04/2024	21:00	GlobeNewswire Inc.	Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer	NYSE:NVS	Novartis AG
10/04/2024	21:13	IH Market News	Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News	NYSE:NVS	Novartis AG
07/04/2024	06:16	PR Newswire (US)	New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting	NYSE:NVS	Novartis AG
16/02/2024	08:15	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:NVS	Novartis AG
07/02/2024	08:52	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NYSE:NVS	Novartis AG
06/02/2024	22:14	IH Market News	Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More	NYSE:NVS	Novartis AG
06/02/2024	09:06	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NYSE:NVS	Novartis AG
03/02/2024	06:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:NVS	Novartis AG
31/01/2024	23:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
31/01/2024	23:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
31/01/2024	23:42	Edgar (US Regulatory)	Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).	NYSE:NVS	Novartis AG
31/01/2024	23:38	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NYSE:NVS	Novartis AG
31/01/2024	22:28	IH Market News	Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and More	NYSE:NVS	Novartis AG
22/01/2024	17:59	Dow Jones News	Sandoz to Acquire Cimerli Business from Coherus for $170 Million	NYSE:NVS	Novartis AG
12/01/2024	22:10	IH Market News	Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More	NYSE:NVS	Novartis AG
12/01/2024	05:02	Dow Jones News	Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal	NYSE:NVS	Novartis AG
09/01/2024	05:43	Dow Jones News	Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal	NYSE:NVS	Novartis AG
09/01/2024	02:41	Dow Jones News	Novartis on Track for Record High Close -- Data Talk	NYSE:NVS	Novartis AG
08/01/2024	22:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
08/01/2024	18:01	Dow Jones News	Novartis's Scemblix Drug Meets Main Goals in Late-Stage Leukemia Trial	NYSE:NVS	Novartis AG
06/01/2024	02:15	Dow Jones News	Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant	NYSE:NVS	Novartis AG
02/01/2024	23:46	Dow Jones News	Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration	NYSE:NVS	Novartis AG
11/12/2023	22:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
11/12/2023	18:02	Dow Jones News	Novartis Drug Meets Primary Goal in Late-Stage Study for Kidney Disease	NYSE:NVS	Novartis AG
11/12/2023	11:39	PR Newswire (US)	Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)	NYSE:NVS	Novartis AG
06/12/2023	21:14	Dow Jones News	Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials	NYSE:NVS	Novartis AG
06/12/2023	16:18	PR Newswire (US)	Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH	NYSE:NVS	Novartis AG
05/12/2023	22:25	IH Market News	Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio Plans Major Layoffs, and More	NYSE:NVS	Novartis AG

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

JP Morgan Chase

Invesco QQQ Trust Series 1

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions